Dr. Feldman Discusses Metabolomic Findings in Prostate Cancer

Adam Scott Feldman, MD, MPH
Published: Wednesday, Aug 23, 2017



Adam Scott Feldman, MD, MPH, urologist at Massachusetts General Hospital, assistant professor of surgery, Harvard Medical School, discusses metabolomic findings in prostate cancer.

Even biopsies that do not show cancer, but are near cancer, have similar metabolomic changes to the specimens nearby that show cancer, says Feldman.

Feldman hopes that these metabolomic findings can be translated into regular prostate MRIs.
 
SELECTED
LANGUAGE


Adam Scott Feldman, MD, MPH, urologist at Massachusetts General Hospital, assistant professor of surgery, Harvard Medical School, discusses metabolomic findings in prostate cancer.

Even biopsies that do not show cancer, but are near cancer, have similar metabolomic changes to the specimens nearby that show cancer, says Feldman.

Feldman hopes that these metabolomic findings can be translated into regular prostate MRIs.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x